Stem Cell Research

Mesenchymal Stem Cells as a Spinal Cord Injury Therapy Opportunity

Spinal cord injury (SCI) often results in damage to the spinal cord or the nerves found within the spinal column. Currently estimated to affect over 17,000 new patients each year in the United States, with 81% of these patients being male, the most common causes of SCIs are motor vehicle accidents, falls, acts of violence,…

The Long-term Results of Managing Degenerative Disc Disease with Allogeneic Mesenchymal Stem Cells

Currently, it's estimated that over 40% of adults over the age of 40 have at least one degenerative disc in their vertebrae; by age 80, the percentage afflicted with this condition is estimated to be over 80%. Characterized by erosion of the rubber-like discs between each vertebra of the spine, degenerative disc degeneration often results…

Evaluating The Immunomodulatory Effects of High Dose Intravenous Administration of Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are multipotent fibroblast-like cells found throughout the body and have been found to have self-renewing and multilinear therapeutic potential by providing new cells for tissue repair by replacing damaged cells.  Thought to stimulate repair and control the immune response through an expression of growth factors and other cytokines, MSCs are at…

Mesenchymal Stem Cells and Osteoarthritis

Osteoarthritis (OA) is the most common form of arthritis and affects an estimated 25% of adults in the United States. Characterized by pain, stiffness, and inflammation in the joints of the body, OA is most frequently observed in the knees, hands, hips, and spine. OA is one of the leading causes of disability with an annual…

A Review of Circulating Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) have been widely used in a number of applications designed to aid in the regeneration and healing of human tissue. Prized for their multipotent capacity to differentiate into a variety of other specific cell types, MSCs have consistently demonstrated the ability to seek out damaged tissue while also reducing inflammation and promoting…

Regenerative Medicine For Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common cause of dementia, accounting for an estimated 50%-70% of dementia cases worldwide.  Characterized by memory loss and cognitive impairment, AD is progressive, debilitating, and fatal.  In addition, it’s estimated that new cases of AD around the globe are occurring at a staggering rate of 20 per minute with…

Mesenchymal Stem Cell-Based Therapy for Type 1 Diabetes

Currently, it’s estimated that nearly 1.5 million Americans are living with type 1 diabetes (T1D), a number that is expected to increase to over 2 million by the year 2040[1].  In the U.S. alone, healthcare costs and lost wages directly related to T1D currently exceed $16 billion per year.   While the most common treatment…

Mesenchymal Stem Cell-Based Therapy For Rheumatoid Arthritis

Mesenchymal stem cells (MSCs) have demonstrated the ability to differentiate into a number of different cells; they also demonstrate immunomodulatory properties that have great potential for use as a stem cell-based therapeutic treatment option and for the treatment of autoimmune diseases - including rheumatoid arthritis (RA). RA is a chronic and debilitating inflammatory disorder that…

Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases

The number of people experiencing autoimmune diseases (ADs) continues to increase worldwide. Currently, it's estimated that between 2 and 5% of the global population is afflicted with the most severe forms of these diseases, including type 1 diabetes (T1DM), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA).  An autoimmune disease can occur nearly anywhere in…

Can Stem Cells Help Brain Injury?

Every year, approximately 350,000 Americans experience severe and moderate traumatic brain injuries (TBI) that can result in long-term disabilities. Unfortunately, there are no effective treatments to improve the structural repair and recovery of function in patients who suffer from a TBI.  Regenerative medicine methodologies, and stem cells, in particular, offer the most promising options for…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.